14
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T79823 | DGKα-IN-4 | ||
DGKα-IN-4 (example 432), an inhibitor of DGKα with an IC50 value of 0.1 nM. This compound notably potentiates the anti-tumor efficacy of anti-PD-1 therapy through augmentation of T cell proliferation and function. Additi... | |||
T79826 | DGKα-IN-6 | ||
DGKα-IN-6, a diacylglycerol kinase alpha (DGKα) inhibitor characterized by an inhibitory concentration (IC50) of 1.377 nM,holds promise for use in cancer research. | |||
T79828 | DGKα-IN-8 | ||
DGKα-IN-8 (Example 51) is a potent diacylglycerol kinase alpha (DGKα) inhibitor, exhibiting an IC50 of 22.491 nM and an EC50 of 0.256 nM. It is applicable in the research of cancer, particularly solid tumors, and viral i... | |||
T79827 | DGKα-IN-7 | ||
DGKα-IN-7 is a potent DGKα inhibitor with an IC50 value of 6.225 nM and potential applications in cancer research. | |||
T79822 | DGKα-IN-3 | ||
DGKα-IN-3 (example 25), with an IC50 of 283 nM, is a selective DGKα inhibitor that augments anti-PD-1's anti-tumor activity by promoting T cell proliferation and function, showing promise for cancer and immunology resear... | |||
T79821 | DGKα-IN-2 | ||
DGKα-IN-2 (example 48), a potent DGKα inhibitor with an IC50 of 0.9 nM, exhibits potential for cancer and immunological research by significantly augmenting the anti-tumor efficacy of anti-PD-1 therapy through the amplif... | |||
T79824 | DGKα&ζ-IN-1 | ||
DGKα&ζ-IN-1 (Compound II) is an inhibitor targeting DGK that potentiates T-cell function and exhibits a synergistic interaction with PD-1, offering therapeutic benefits in immune and tumor contexts [1]. | |||
T77760 | BMS-684 | Others | |
BMS-684 is a selective and potent DGKα inhibitor (IC50: 15 nM) with potential antitumor activity.BMS-684 inhibits DGKα kinase, DGKβ, and DGKγ.BMS-684 activates T-cells, which may prevent and treat immune-related diseases... | |||
T26019 | R59949 | R-59949,R 59949 | Others , PKC |
R59949 is used as a Diacylglycerol kinase (DGK) inhibitor. | |||
T10177 | (5Z,2E)-CU-3 | Apoptosis | |
(5Z,2E)-CU-3 is a potent and selective inhibitor of DGKα isozyme with an IC50 value of 0.6 μM and inhibition of DGKα by competing ATP with a Km value of 0.48 mM. (5Z,2E)-CU-3 is selective, targeting the catalytic region ... | |||
T82850 | BMS-332 | ||
BMS-332 is a dual inhibitor of the lipid kinases DGKα and DGKζ, demonstrating half-maximal inhibitory concentrations (IC50) of 0.005 μM for DGKα and 0.001 μM for DGKζ [1]. | |||
T82849 | BMS-496 | ||
BMS-496 is a dual DGKα/ζ lipid kinase inhibitor exhibiting IC50 values of 0.09 μM (DGKα) and 0.006 μM (DGKζ) [1]. | |||
T63207 | JNJ-3790339 | ||
JNJ-3790339 is an analogue of Ritanserin, a selective and potent diacylglycerol kinase (DGKα) inhibitor (IC50: 9.6 μM) that upregulates T-cell activation and induces toxic effects on malignant cells. | |||
T79819 | AMB639752 | ||
AMB639752 is a potent inhibitor of diacylglycerol kinase alpha (DGKα) that reinstates restimulation-induced cell death (RICD) in SAP-deficient lymphocytes through DGKα inhibition within intact cells. This compound is app... |